[关于骨髓甲状腺癌的更新 - - 对外科医生来说有什么意义?]
Kerstin Lorenz1, Andreas Machens2, Henning Dralle3
1Klinik für Viszerale, Gefäß- und Endokrine Chirurgie, Universitätsmedizin Halle, Ernst-Grube-Str. 40, 06120, Halle/Saale, Deutschland. kerstin.lorenz@uk-halle.de.
Chirurgie (Heidelberg, Germany)
|May 19, 2025
概括
这篇文章回顾了状甲状腺癌 (MTC) 的手术策略,重点关注风险因素,切除技术和遗传病例的预防性甲状腺切除术. 它与针对最佳患者护理的最新国家指南保持一致.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 遗传学 是一个遗传学.
背景情况:
- 骨髓甲状腺癌 (MTC) 提出了独特的诊断和手术挑战.
- 了解风险因素和遗传倾向对于有效管理至关重要.
- 目前的治疗策略正在根据最近的研究和指南更新而发展.
研究的目的:
- 提供MTC手术相关的诊断和操作方面的概述.
- 讨论国家指导方针 (S3) 中的当前趋势和预期的调整.
- 概述个性化的治疗选择,切除策略和预防方法.
主要方法:
- 关于甲状腺髓癌的最新研究的综述.
- 对诊断和操作方面的分析.
- 检查风险因素,切除策略和预防性甲状腺切除术概念.
主要成果:
- 个性化治疗是基于可识别的风险因素.
- 讨论了标准化的手术内切除策略和程序.
- 散发性和遗传性MTC的特征详细说明,包括预防性甲状腺切除术.
结论:
- 进行MTC的手术治疗需要采用量身定制的方法,考虑到风险分层.
- 预防性甲状腺切除术是遗传性MTC的一个关键考虑因素.
- 遵守最新的指导方针和当前的趋势可以确保最佳的患者结果.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


